Grants for Public and State controlled institutions of higher education - Federal

This grant provides funding to neuroscience researchers to advance their small molecule drug discovery and development projects aimed at treating disorders of the nervous system.

To increase research capacity for NF, the NFRP is offering the NFRA. The intent of the NFRA is to provide a framework of intensive mentoring and iterative guidance with proposed research, national networking, collaborations, and a peer group of junior faculty (Scholars). The NFRP NFRA will bring together established NF investigators (one Director and one Deputy Director) and early-career independent investigators (Scholars) and their Career Guides to develop successful, highly productive NF scientists and clinicians that will conduct research with the aim of lessening the clinical impact of NF1, NF2, and schwannomatosis. The NFRA is a multi-institutional interactive virtual academy platform designed to offer support to NFRA Scholars with the goal to advance innovative, high impact NF research through a collaborative and career development environment.The functioning NFRA will consist of Scholars and their Career Guides (mentors) from different institutions, and an Academy Director and Deputy Director (see Figure 1 below). The Academy Director and Deputy Director will catalyze the growth and professional development of the Scholars in collaboration with their Career Guides, assess the progress of the Scholars, and facilitate communication and collaboration among all Academy members. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, a secondary Career Guide at the Scholars institution is needed. The NFRA will afford Scholars opportunities to operate in a collegial, highly dynamic, and cutting-edge center to move early-career investigators towards positions as leaders in NF conducting impactful research.During this first phase of the academy, the NFRP is offering the FY24 NFRALA funding opportunity to solicit applications for an Academy Director and Deputy Director to lead the NFRA. The Academy Director and Deputy Director (referred to as Academy Leadership) must be established NF researchers and can be at different institutions. The Academy Leadership must demonstrate a strong record of mentoring and training early-career independent investigators, a commitment to leadership, the ability to articulate methods toward research collaborations, and the ability to objectively assess the progress of all Scholars in the NFRA. An objective of the NFRA leadership team is to establish the Academy structure in its first year and in subsequent years, conduct oversight of this activity. Other objectives will include execution of research that will engage NFRA FY25 Scholars (including subsequent-year Scholars), develop tools for Scholars to enable success, and provide opportunities to broaden their knowledge in NF disorders. The leadership team will identify and offer opportunities to network with other NFRP FY25 Early Investigator Research Award recipients (and subsequent year awardees) and NFRP FY25 New Investigator Award Early-Stage Investigator (NIA ESI) Award recipients (and subsequent year awardees). In the second stage of the academy, the NFRP anticipates release of funding opportunities for the Scholars who will conduct their research under the guidance of the NFRA leadership team.

This funding opportunity provides financial support for projects focused on ecosystem restoration and environmental resilience in American Samoa, Guam, the Northern Mariana Islands, and the U.S. Virgin Islands, targeting local governments, educational institutions, and nonprofits serving these areas.

This funding opportunity supports academic and industrial partnerships to develop new vaccines aimed at preventing tuberculosis infection and disease, addressing the urgent need for effective solutions against rising TB rates.

This funding opportunity provides financial support to various organizations to assist the Botswana Ministry of Health in implementing effective HIV prevention and treatment programs, particularly for underserved populations.

The "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II" grant aims to expand the existing mental health research network to include larger studies, provide guidance to the scientific community, and support career development for researchers from low-resource settings worldwide.

This funding opportunity supports early-career scientists in the U.S. who are focused on conducting impactful research to improve worker health and safety in various industries.

This funding opportunity supports not-for-profit organizations and individuals in Myanmar to implement projects that promote education, entrepreneurship, media literacy, and cultural exchange with the United States.

This funding opportunity supports educational programs that promote diversity in neuroscience research by providing mentoring, research experiences, and skill development for underrepresented individuals in the field.

This funding opportunity supports researchers in exploring and validating the biological mechanisms linking HIV, substance use disorders, and opioid exposure at a single-cell level, with a focus on data mining existing datasets and conducting functional validation studies.

This grant provides funding for researchers to develop and test innovative behavioral treatments for individuals struggling with drug and alcohol misuse, particularly focusing on improving treatment effectiveness and accessibility for diverse populations.

This program will help rural hospitals expand their services to meet community health needs while increasing their revenues. The program will achieve these goals by providing expert technical assistance to rural hospitals to conduct market assessments, determine ways to enhance existing service lines, and start new service lines to keep services locally. The program will also provide direct financial support to help with associate costs of service lines. This program will also have the affect of helping facilities address long-standing rural disparities.

This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.

The Bureau of Counterterrorism (CT) of the U.S. Department of State is inviting applications to support the Bangladeshi initiative aimed at rehabilitating and reintegrating terrorist offenders. This program, executed by the Dhaka Metropolitan Police’s Counterterrorism and Transnational Crime unit (DMP/CTTC) in collaboration with the non-government organization Centre for Alternatives (CFA), seeks to enhance efforts in rehabilitating terrorist offenders to prevent and counter violent extremism effectively.

This grant provides funding to nonprofit organizations and government entities to deliver essential family planning and reproductive health services to low-income and underserved populations across the United States.

This funding opportunity supports U.S. and non-U.S. organizations in developing a summer camp that enhances leadership and entrepreneurship skills for Kazakh youth aged 15 to 19 who were semi-finalists for U.S. Government youth exchange programs.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA (see RFA-HL-22-011).

The Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) aims to support licensed neurologists and neurosurgeons in the NINDS intramural program as they transition to independent academic positions while leading clinical trials and advancing their research careers in neuroscience.

This funding opportunity supports research projects that investigate the long-term impacts of disasters on healthcare systems serving vulnerable populations in the U.S., aiming to improve access and reduce health disparities.

This funding opportunity supports U.S.-based small businesses in the clinical validation of biomarkers for neurological or neuromuscular disorders, promoting inclusivity and collaboration while ensuring rigorous scientific standards for potential diagnostic and therapeutic applications.